Figure 1
Typical Injection Sites under EMG Guidance. IncobotulinumtoxinA. . = 2.5 u/0.05 mL; : = 5 u/0.1 mL; :: = 10 u/0.2 mL.
Table 1
Outcome Scale Based on Patient Report and Examiner’s Assessment Performed at Each Botulinum Injection Session
| Current (pre-injection) disability 0 No disability or functional impairment 1 Mild disability or functional impairment 2 Mild–moderate disability or functional impairment 3 Moderate disability or functional impairment 4 Moderate–severe disability or functional impairment 5 Severe disability or functional impairment 6 Completely incapacitated |
| Disability at patient's best following last botulinum toxin injection session 0 No disability or functional impairment 1 Mild disability or functional impairment 2 Mild–moderate disability or functional impairment 3 Moderate disability or functional impairment 4 Moderate–severe disability or functional impairment 5 Severe disability or functional impairment 6 Completely incapacitated |